The U.S. Food and Drug Administration (FDA) has approved a new tablet formulation of Evrysdi (risdiplam), an approved oral ...

Parkinson's Disease Treatment Market Aging Populations and Advancements in Deep Brain Stimulation, Gene Therapy, and Medications Fuel Marke ...

Americans will soon have access to an infusion device that provides round-the-clock effective relief of Parkinson's disease.

The discovery and development of GLP-1 receptor agonists for type 2 diabetes and obesity is a bench-to-bedside success story.1 Multiple GLP-1 receptor agonists are now in clinical use, such as ...

Today’s approval of ONAPGO means patients in the U.S. who are not responding well to their current treatment regimen, including levodopa, will now have the option of using a small and lightweight ...

NEW YORK, NY / ACCESS Newswire / February 4, 2025 / Laxxon Medical, a leading pharmaceutical technology company pioneering a new generation of advanced drug ...

Table 1. Percentage of patients decreasing daily levodopa dose by 4–6 weeks after entacapone initiation in Phase III clinical trials as grouped by baseline daily levodopa dose and presence of ...

They were randomized to flexible doses of Stalevo or levodopa/carbidopa IR administered four-times daily on a q3.5 h schedule with a target dose of approximately 400 mg levodopa per day.

Turmeric is typically taken in doses of 1.5 grams daily for up to three months ... such as Aldactone and CaroSpir (spironolactone) Zinc Sinemet (levodopa/carbidopa) Check with a healthcare provider or ...

Reviewers have tested some of the products below and may have received some products from the manufacturers for free. All opinions are the reviewers’ own. These full-spectrum gummies are ...

This article will discuss the recommended hepatitis vaccine schedule for children and adults, including doses, timing, side effects, and who should get the vaccine. The following vaccines are approved ...

PHOTO/Shutterstock The European Commission, through its Health Emergency Preparedness and Response Authority (HERA), has delivered 10,000 doses of the MVABN® vaccine to Uganda to support the ...